By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on GatePass Capital's CBIZ position, citing structural headwinds, potential margin compression, and uncertainty around the company's acquisition-driven growth model in a high-rate environment.
Risk: Debt-fueled acquisition model breaking under higher interest rates, leading to a terminal multiple of 0.7x P/S instead of a floor.
Opportunity: None identified, as the potential benefits of an insurance commission tailwind were deemed uncertain and speculative.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
GatePass Capital, LLC acquired 98,163 shares of CBIZ; estimated transaction value is $3.46 million based on average quarterly price.
The quarter-end position value increased by $2.64 million, reflecting both the share purchase and changes in CBIZ's stock price.
The trade represented a 1.62% shift in GatePass Capital, LLC's 13F reportable assets under management.
Post-trade stake: 98,163 shares valued at $2.64 million, accounting for 1.23% of fund AUM.
This new position places CBIZ outside the fund’s top five holdings after the trade.
On May 6, 2026, GatePass Capital, LLC disclosed a new position in CBIZ (NYSE:CBZ), acquiring 98,163 shares in an estimated $3.46 million trade based on the quarterly average price.
According to a Securities and Exchange Commission (SEC) filing dated May 6, 2026, GatePass Capital, LLC initiated a new position in CBIZ, purchasing 98,163 shares. The estimated transaction value was approximately $3.46 million, calculated using the average unadjusted closing price for the first quarter of 2026. The quarter-end value of the position was $2.64 million, reflecting both trading activity and share price movement.
This was a new position for GatePass Capital, LLC, representing 1.23% of its reportable assets under management as of March 31, 2026.
Top five holdings after the filing:
As of May 5, 2026, CBIZ shares were priced at $31.30, down 56.5% over the past year, and underperforming the S&P 500 by 85.0 percentage points.
| Metric | Value | |---|---| | Revenue (TTM) | $2.77 billion | | Net income (TTM) | $154.28 million | | Price (as of market close May 5, 2026) | $31.30 | | One-year price change | (56.5%) |
CBIZ is a leading provider of professional services, leveraging a multi-segment platform to deliver financial, insurance, and advisory solutions. Its scale and breadth of offerings allow it to address a wide range of client needs, supporting organizations through complex regulatory and operational environments. CBIZ's diversified client base and recurring revenue streams provide resilience and growth opportunities within the specialty business services sector.
GatePass Capital, an Ohio-based investment advisor, recently disclosed the purchase of $2.6 million worth of CBIZ stock (CBZ) during the first quarter (the three months ending on March 31, 2026). Here are some key takeaways for investors.
To begin, CBIZ stock has struggled recently. Shares have declined in value by around 55% over the past year. The company delivered a disappointing first-quarter earnings report. Revenue came in below consensus analyst expectations, and management lowered guidance, citing demand uncertainty.
All that said, some investors may be intrigued by the stock’s newfound affordability. Shares now trade at a price-to-sales (P/S) ratio of around 0.7x. That’s far below the stock’s 10-year average P/S ratio of 1.5x, and it’s close to the 10-year low of 0.6x, recorded earlier this year.
In summary, CBIZ stock has come under pressure due to disappointing results and lowered guidance. However, value-minded investors may want to give the stock a closer look due to its low valuation.
Before you buy stock in CBIZ, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CBIZ wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $475,926! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,296,608!
Now, it’s worth noting Stock Advisor’s total average return is 981% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 8, 2026. *
Jake Lerch has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The deep discount in CBIZ's valuation reflects deteriorating fundamentals and slowing demand rather than a mispriced growth opportunity."
GatePass Capital’s entry into CBIZ at a 0.7x price-to-sales ratio looks like a classic value trap rather than a bargain. While the valuation is historically depressed, the 56.5% year-over-year decline and management’s lowered guidance signal structural headwinds in their professional services segments, likely driven by a slowdown in corporate spending. A 1.23% AUM allocation is a 'toe-dip' position, not a conviction play. Investors should be wary: in a high-rate or slowing growth environment, professional services firms often suffer from margin compression as clients slash discretionary consulting and insurance premiums. Without a clear catalyst for margin expansion, the stock remains a falling knife.
If CBIZ is undergoing a cyclical trough, the current 0.7x P/S ratio provides a massive margin of safety for a firm that holds critical, recurring-revenue contracts in tax and payroll services.
"GatePass's modest position size reflects low conviction amid CBIZ's fundamental deterioration and macro headwinds in professional services."
GatePass Capital's new CBIZ stake is tiny—1.23% of AUM, outside top 5 holdings heavy on defensive CINF (insurer) and liquid ETFs like SPY/SHV. CBIZ cratered 56.5% in a year after Q1 revenue miss and slashed guidance citing demand uncertainty in accounting/tax/insurance brokerage for SMBs. P/S at 0.7x (vs 1.5x 10-yr avg) looks cheap, but TTM revenue $2.77B with $154M net income masks segment weakness; professional services face recession risks as clients defer non-essential advisory. Low conviction buy signals caution, not bargain hunt—needs Q2 beats for re-rating.
GatePass could be early on a turnaround, betting CBIZ's recurring revenue streams and cross-selling scale rebound with SMB spending normalization, turning 0.7x P/S into a multi-bagger like past cycles.
"A small fund buying a beaten-down professional services stock after a 56% crash and guidance cut is not evidence of hidden value—it's a classic value trap in a cyclical downturn."
This article conflates a small tactical position with fundamental investment thesis. GatePass Capital's $2.64M stake (1.23% of AUM) is immaterial—barely a rounding error for a fund managing ~$200M. The real red flag: CBIZ down 56.5% YoY on missed revenue, lowered guidance, and demand uncertainty. The article's 'value trap' framing (0.7x P/S vs. 1.5x historical) ignores why the multiple compressed: professional services are cyclical, and if demand is genuinely weakening, that 0.7x may be fair or even generous. GatePass's entry timing—after the crash, not before—suggests they're catching a falling knife, not prescient. The article never addresses whether CBIZ's recurring revenue actually recurs if clients cut advisory spending.
If demand uncertainty is temporary and CBIZ's client base is sticky (recurring revenue model), the 56.5% drawdown could be overcorrection; a modest guidance beat in Q2 could re-rate the stock 30-40% higher, making GatePass's entry prescient.
"CBIZ faces ongoing demand headwinds and a weak SMB funding cycle, making a near-term re-rating unlikely despite the low valuation."
GatePass Capital's new CBIZ position reads as a contrarian bet that the stock's 56% annual drop and sub-1x P/S implies a floor, but several issues argue against a near-term rebound. The Q1 miss and guide-down suggest still-weak demand for professional services, while CBIZ's earnings quality and client mix are exposed to SMB funding cycles. The stake is small (~1.23% of AUM) and far from a conviction-level position, so it could be a lightweight reweighting or a hedge rather than an explicit turnaround call. The headline 13F snapshot omits ongoing fundamentals, margin trajectory, and cash-flow dynamics, limiting payoff without a clear catalyst.
Strongest counterpoint: GatePass may simply be nibbling at an illiquid name or engaging in portfolio rebalancing; the fundamental troubles in CBIZ are not resolved by a small new stake, and a catalyst may be years out if at all.
"CBIZ's valuation collapse reflects the failure of its inorganic M&A-driven growth model, not just cyclical weakness in advisory services."
Claude is right that the position size is trivial, but everyone is over-indexing on the 'professional services' label. CBIZ is fundamentally a roll-up strategy. Its growth has historically been inorganic, driven by aggressive M&A in the fragmented accounting and benefits space. The risk isn't just organic demand; it's whether their debt-fueled acquisition model breaks under higher interest rates. If they can't afford to buy growth, the 0.7x P/S isn't a floor—it's a terminal multiple.
"CBIZ's low leverage and insurance hard-market tailwinds mitigate M&A slowdown risks others emphasize."
Gemini flags a sharp M&A/debt risk, but overlooks CBIZ's balance sheet: net debt/EBITDA ~2x (pre-high rates), with $154M TTM net income supporting interest coverage >5x. High rates crimp deals short-term, yet insurance brokerage thrives in hard markets (premiums up 10-15% YoY industry-wide), providing organic offset. Panel fixates on demand weakness; this segment's commission tailwind could stabilize margins before Q2.
"Insurance commission upside doesn't automatically rescue tax/accounting decline if debt service consumed that margin improvement."
Grok's insurance commission tailwind is real, but assumes CBIZ's brokerage segment can offset organic weakness in tax/accounting—unproven. More critically: Grok cites 2x net debt/EBITDA 'pre-high rates' as historical, not current. If rates stayed elevated 18+ months, that ratio likely deteriorated. The 5x interest coverage claim needs current TTM verification. Without Q2 segment breakdown showing brokerage offsetting advisory softness, we're betting on a cross-subsidy that may not materialize.
"0.7x P/S as a floor is not robust for a debt-funded roll-up; rising rates and integration risk can push the multiple lower unless M&A creates durable cross-sell growth and free cash flow."
Gemini's claim that 0.7x P/S is a floor overlooks CBIZ's roll-up risk. If growth relies on debt-funded acquisitions, higher rates compress funding capacity and weigh on M&A margins, not just near-term demand. A sub-1x multiple could re-rate downward if debt costs rise or if integration fails to unlock expected cross-sell synergies. The mere size of GatePass's stake doesn't prove durability; liquidity and capital allocation risk deserve more weight in the thesis.
The panel consensus is bearish on GatePass Capital's CBIZ position, citing structural headwinds, potential margin compression, and uncertainty around the company's acquisition-driven growth model in a high-rate environment.
None identified, as the potential benefits of an insurance commission tailwind were deemed uncertain and speculative.
Debt-fueled acquisition model breaking under higher interest rates, leading to a terminal multiple of 0.7x P/S instead of a floor.